Stryker Research Development vs Reconciled Depreciation Analysis

SYK Stock

USD 335.61 1.54 0.46%

Stryker financial indicator trend analysis is much more than just breaking down Stryker prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stryker is a good investment. Please check the relationship between Stryker Research Development and its Reconciled Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stryker Research Development account and Reconciled Depreciation. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Stryker's Research Development and Reconciled Depreciation is 0.9. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Stryker, assuming nothing else is changed. The correlation between historical values of Stryker's Research Development and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Stryker are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Research Development i.e., Stryker's Research Development and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Reconciled Depreciation

Most indicators from Stryker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 116.9 B this year, although the value of Tax Provision will most likely fall to about 289.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	11.0B	11.6B	13.1B	13.7B
Total Revenue	17.1B	18.4B	20.5B	21.5B

Gross Profit Total Revenue

Stryker fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Short Term Investments	Current Deferred Revenue
Total Assets		0.97	0.95	0.94	0.97	0.99	0.94	0.98	0.65	0.99	0.93	-0.01	0.99	0.63	0.95	0.98	-0.05	0.97	0.99	0.87	0.74	0.95	0.94	0.91	-0.5	0.35
Short Long Term Debt Total	0.97		0.88	0.87	0.9	0.98	0.98	0.92	0.63	0.99	0.91	-0.15	0.94	0.47	0.99	0.95	-0.23	0.89	0.99	0.75	0.67	0.97	0.9	0.89	-0.65	0.39
Other Current Liab	0.95	0.88		0.94	0.94	0.91	0.84	0.94	0.63	0.91	0.85	0.17	0.93	0.67	0.87	0.91	0.14	0.95	0.93	0.91	0.71	0.88	0.86	0.83	-0.31	0.29
Total Current Liabilities	0.94	0.87	0.94		0.94	0.91	0.85	0.95	0.54	0.91	0.89	-0.01	0.93	0.67	0.81	0.96	0.06	0.92	0.9	0.87	0.88	0.81	0.93	0.89	-0.37	0.38
Total Stockholder Equity	0.97	0.9	0.94	0.94		0.96	0.88	1.0	0.59	0.94	0.9	0.05	0.99	0.73	0.87	0.97	0.08	0.98	0.93	0.92	0.75	0.87	0.95	0.92	-0.37	0.29
Property Plant And Equipment Net	0.99	0.98	0.91	0.91	0.96		0.95	0.97	0.67	0.99	0.94	-0.06	0.98	0.58	0.97	0.98	-0.13	0.95	0.99	0.84	0.73	0.96	0.92	0.9	-0.58	0.36
Net Debt	0.94	0.98	0.84	0.85	0.88	0.95		0.89	0.46	0.98	0.87	-0.28	0.91	0.43	0.95	0.92	-0.22	0.84	0.96	0.67	0.63	0.92	0.92	0.91	-0.6	0.5
Retained Earnings	0.98	0.92	0.94	0.95	1.0	0.97	0.89		0.63	0.96	0.91	0.04	0.99	0.71	0.89	0.98	0.03	0.98	0.95	0.91	0.75	0.9	0.95	0.92	-0.41	0.29
Cash	0.65	0.63	0.63	0.54	0.59	0.67	0.46	0.63		0.61	0.65	0.37	0.64	0.42	0.69	0.63	-0.17	0.68	0.68	0.68	0.51	0.71	0.44	0.4	-0.52	-0.18
Non Current Assets Total	0.99	0.99	0.91	0.91	0.94	0.99	0.98	0.96	0.61		0.94	-0.14	0.96	0.54	0.97	0.98	-0.18	0.93	0.99	0.79	0.71	0.96	0.94	0.92	-0.6	0.38
Non Currrent Assets Other	0.93	0.91	0.85	0.89	0.9	0.94	0.87	0.91	0.65	0.94		-0.11	0.91	0.53	0.89	0.93	-0.21	0.89	0.93	0.75	0.79	0.89	0.89	0.87	-0.61	0.24
Cash And Short Term Investments	-0.01	-0.15	0.17	-0.01	0.05	-0.06	-0.28	0.04	0.37	-0.14	-0.11		0.0	0.27	-0.06	-0.09	0.73	0.15	-0.05	0.42	-0.12	0.0	-0.23	-0.28	0.55	-0.22
Net Receivables	0.99	0.94	0.93	0.93	0.99	0.98	0.91	0.99	0.64	0.96	0.91	0.0		0.67	0.91	0.99	-0.02	0.98	0.96	0.89	0.75	0.91	0.95	0.92	-0.47	0.3
Common Stock Shares Outstanding	0.63	0.47	0.67	0.67	0.73	0.58	0.43	0.71	0.42	0.54	0.53	0.27	0.67		0.45	0.64	0.32	0.74	0.54	0.81	0.54	0.49	0.59	0.54	0.09	-0.03
Non Current Liabilities Total	0.95	0.99	0.87	0.81	0.87	0.97	0.95	0.89	0.69	0.97	0.89	-0.06	0.91	0.45		0.91	-0.22	0.88	0.98	0.75	0.59	0.99	0.83	0.82	-0.64	0.37
Inventory	0.98	0.95	0.91	0.96	0.97	0.98	0.92	0.98	0.63	0.98	0.93	-0.09	0.99	0.64	0.91		-0.1	0.95	0.97	0.85	0.82	0.91	0.95	0.92	-0.53	0.34
Other Current Assets	-0.05	-0.23	0.14	0.06	0.08	-0.13	-0.22	0.03	-0.17	-0.18	-0.21	0.73	-0.02	0.32	-0.22	-0.1		0.08	-0.14	0.35	-0.11	-0.16	-0.11	-0.14	0.84	0.15
Other Stockholder Equity	0.97	0.89	0.95	0.92	0.98	0.95	0.84	0.98	0.68	0.93	0.89	0.15	0.98	0.74	0.88	0.95	0.08		0.93	0.93	0.72	0.9	0.9	0.86	-0.37	0.17
Total Liab	0.99	0.99	0.93	0.9	0.93	0.99	0.96	0.95	0.68	0.99	0.93	-0.05	0.96	0.54	0.98	0.97	-0.14	0.93		0.82	0.71	0.97	0.9	0.88	-0.58	0.39
Total Current Assets	0.87	0.75	0.91	0.87	0.92	0.84	0.67	0.91	0.68	0.79	0.75	0.42	0.89	0.81	0.75	0.85	0.35	0.93	0.82		0.68	0.77	0.76	0.71	-0.11	0.21
Short Term Debt	0.74	0.67	0.71	0.88	0.75	0.73	0.63	0.75	0.51	0.71	0.79	-0.12	0.75	0.54	0.59	0.82	-0.11	0.72	0.71	0.68		0.59	0.76	0.71	-0.43	0.21
Intangible Assets	0.95	0.97	0.88	0.81	0.87	0.96	0.92	0.9	0.71	0.96	0.89	0.0	0.91	0.49	0.99	0.91	-0.16	0.9	0.97	0.77	0.59		0.81	0.79	-0.6	0.3
Accounts Payable	0.94	0.9	0.86	0.93	0.95	0.92	0.92	0.95	0.44	0.94	0.89	-0.23	0.95	0.59	0.83	0.95	-0.11	0.9	0.9	0.76	0.76	0.81		0.99	-0.5	0.38
Property Plant And Equipment Gross	0.91	0.89	0.83	0.89	0.92	0.9	0.91	0.92	0.4	0.92	0.87	-0.28	0.92	0.54	0.82	0.92	-0.14	0.86	0.88	0.71	0.71	0.79	0.99		-0.51	0.4
Short Term Investments	-0.5	-0.65	-0.31	-0.37	-0.37	-0.58	-0.6	-0.41	-0.52	-0.6	-0.61	0.55	-0.47	0.09	-0.64	-0.53	0.84	-0.37	-0.58	-0.11	-0.43	-0.6	-0.5	-0.51		-0.03
Current Deferred Revenue	0.35	0.39	0.29	0.38	0.29	0.36	0.5	0.29	-0.18	0.38	0.24	-0.22	0.3	-0.03	0.37	0.34	0.15	0.17	0.39	0.21	0.21	0.3	0.38	0.4	-0.03

Click cells to compare fundamentals

Stryker Account Relationship Matchups

Stryker fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.2B	34.3B	34.6B	36.9B	39.9B	41.9B
Short Long Term Debt Total	10.2B	13.2B	12.5B	13.0B	13.0B	13.6B
Other Current Liab	2.9B	3.5B	3.4B	3.7B	3.9B	4.1B
Total Current Liabilities	4.4B	5.0B	4.5B	6.3B	7.9B	8.3B
Total Stockholder Equity	12.8B	13.1B	14.9B	16.6B	18.6B	19.5B
Property Plant And Equipment Net	2.6B	2.8B	2.8B	3.0B	3.2B	3.4B
Net Debt	5.9B	10.3B	9.5B	11.2B	10.0B	10.5B
Retained Earnings	11.7B	12.5B	13.5B	14.8B	16.8B	17.6B
Cash	4.3B	2.9B	2.9B	1.8B	3.0B	3.1B
Non Current Assets Total	18.8B	24.6B	24.6B	26.6B	27.4B	28.8B
Non Currrent Assets Other	1.4B	2.0B	2.2B	2.4B	2.7B	2.8B
Cash And Short Term Investments	4.4B	3.0B	3.0B	1.9B	3.1B	1.7B
Net Receivables	2.9B	2.7B	3.0B	3.6B	3.8B	4.0B
Liabilities And Stockholders Equity	30.2B	34.3B	34.6B	36.9B	39.9B	41.9B
Non Current Liabilities Total	13.0B	16.2B	15.2B	14.0B	13.4B	14.1B
Inventory	3.3B	3.5B	3.3B	4.0B	4.8B	5.1B
Other Current Assets	760M	488M	662M	787M	857M	520.6M
Other Stockholder Equity	1.6B	1.7B	1.9B	2.0B	2.2B	2.3B
Total Liab	17.4B	21.2B	19.8B	20.3B	21.3B	22.4B
Total Current Assets	11.4B	9.7B	10.0B	10.3B	12.5B	13.1B
Short Term Debt	859M	761M	7M	1.2B	2.1B	2.2B
Intangible Assets	4.2B	5.6B	4.8B	4.9B	4.6B	4.8B
Accounts Payable	675M	810M	1.1B	1.4B	1.5B	1.6B
Property Plant And Equipment Gross	2.6B	2.8B	5.5B	5.8B	6.3B	6.7B
Accumulated Other Comprehensive Income	(606M)	(1.2B)	(531M)	(221M)	(416M)	(395.2M)
Short Term Investments	88M	81M	75M	84M	82M	77.9M
Good Will	9.1B	12.8B	12.9B	14.9B	15.2B	16.0B
Other Liab	2.4B	3.0B	2.7B	1.8B	2.0B	1.1B
Other Assets	2.6B	3.5B	4.0B	3.9B	4.5B	4.7B
Long Term Debt	10.2B	13.2B	12.5B	11.9B	10.9B	11.4B
Property Plant Equipment	2.6B	2.8B	2.8B	3.0B	3.4B	3.6B
Net Tangible Assets	(489M)	(5.2B)	(2.9B)	(3.1B)	(2.8B)	(2.7B)
Retained Earnings Total Equity	11.7B	12.5B	13.5B	14.8B	17.0B	10.2B
Capital Surpluse	1.6B	1.7B	1.9B	2.0B	2.3B	1.5B
Non Current Liabilities Other	2.7B	3.0B	1.8B	1.5B	1.9B	1.8B
Accumulated Depreciation	(2.1B)	(2.4B)	(2.7B)	(2.8B)	(2.6B)	(2.7B)

Currently Active Assets on Macroaxis

GM	General Motors
S	SentinelOne
MSFT	Microsoft
C	Citigroup
F	Ford Motor

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:

How To Invest In Stryker

Details

Is Stryker Stock a good investment?

Details

What is Stryker's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.

	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like

Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.027

Dividend Share

3.05

Earnings Share

8.25

Revenue Per Share

53.999

Quarterly Revenue Growth

0.118

The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Stryker Research Development vs Reconciled Depreciation Analysis

Research Development vs Reconciled Depreciation

Research Development vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Research Development

Reconciled Depreciation

Stryker fundamental ratios Correlations

Stryker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Stryker fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Stryker Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Short Long Term Debt Total

Short Term Investments	- 0.65	Short Long Term Debt Total
Short Term Investments	- 0.64	Non Current Liabilities Total
Short Term Investments	- 0.61	Non Currrent Assets Other
Short Term Investments	- 0.6	Intangible Assets
Short Term Investments	- 0.6	Non Current Assets Total
Short Term Investments	- 0.6	Net Debt